Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Martin Watterson

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|February 25, 2009
Structural insight into nucleotide recognition by human death-associated protein kinaseLaurie K McNamara, D Martin Watterson, Joseph S Brunzelle
Alzheimer Disease and Associated Disorders|June 19, 2002
Barriers to Alzheimer disease drug discovery and development in academiaLinda J Van Eldik, Tanuja Koppal, D Martin Watterson
Biochimica Et Biophysica Acta. Molecular Cell Research|July 24, 2021
Phosphorylation-dependent subcellular redistribution of small myosin light chain kinaseAsker Y Khapchaev, D Martin Watterson, Vladimir P Shirinsky
Expert Opinion on Therapeutic Targets|September 12, 2002
Death-associated protein kinase as a potential therapeutic targetAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson
Biochimica Et Biophysica Acta|September 26, 2006
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leakHeather A Behanna, D Martin Watterson, Hantamalala Ralay Ranaivo
Journal of Molecular Neuroscience : MN|September 6, 2002
Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responsesD Martin Watterson, Jacques Haiech, Linda J Van Eldik
Pharmacology & Therapeutics|August 23, 2002
Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal deathAnastasia V Velentza, Andrew M Schumacher, D Martin Watterson
Expert Opinion on Therapeutic Targets|September 28, 2005
Neuroinflammation: a potential therapeutic targetJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Glia|December 22, 2005
Human amyloid beta-induced neuroinflammation is an early event in neurodegenerationJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Nature Reviews. Drug Discovery|October 31, 2009
Targeting protein kinases in central nervous system disordersLaura K Chico, Linda J Van Eldik, D Martin Watterson
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Acta Crystallographica. Section D, Biological Crystallography|February 25, 2009
Structural insight into nucleotide recognition by human death-associated protein kinaseLaurie K McNamara, D Martin Watterson, Joseph S Brunzelle
Alzheimer Disease and Associated Disorders|June 19, 2002
Barriers to Alzheimer disease drug discovery and development in academiaLinda J Van Eldik, Tanuja Koppal, D Martin Watterson
Biochimica Et Biophysica Acta. Molecular Cell Research|July 24, 2021
Phosphorylation-dependent subcellular redistribution of small myosin light chain kinaseAsker Y Khapchaev, D Martin Watterson, Vladimir P Shirinsky
Expert Opinion on Therapeutic Targets|September 12, 2002
Death-associated protein kinase as a potential therapeutic targetAndrew M Schumacher, Anastasia V Velentza, D Martin Watterson
Biochimica Et Biophysica Acta|September 26, 2006
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leakHeather A Behanna, D Martin Watterson, Hantamalala Ralay Ranaivo
Journal of Molecular Neuroscience : MN|September 6, 2002
Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responsesD Martin Watterson, Jacques Haiech, Linda J Van Eldik
Pharmacology & Therapeutics|August 23, 2002
Structure, activity, regulation, and inhibitor discovery for a protein kinase associated with apoptosis and neuronal deathAnastasia V Velentza, Andrew M Schumacher, D Martin Watterson
Expert Opinion on Therapeutic Targets|September 28, 2005
Neuroinflammation: a potential therapeutic targetJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Glia|December 22, 2005
Human amyloid beta-induced neuroinflammation is an early event in neurodegenerationJeffrey M Craft, D Martin Watterson, Linda J Van Eldik
Nature Reviews. Drug Discovery|October 31, 2009
Targeting protein kinases in central nervous system disordersLaura K Chico, Linda J Van Eldik, D Martin Watterson
Pageof 8